Abstract: The present application describes improved an immunogenic compositions of virus vaccines wherein the virus vaccines comprise adjuvants selected from the group consisting of MCP-1, Haemophilus sonmus fractions, carbomer and combinations thereof. Methods and compositions using such improved compositions are described.

Abstract: A method of predicting the virulence of a new or uncharacterized PRRS virus strain is provided wherein the strain is injected into swine and allowed to replicate for a period of from about 3-15 days. During this period, the rate of virus growth and/or the magnitude of viremia is determined, and this data is compared with a corresponding growth rate and/or viremia magnitude of a PRRS virus strain of known virulence, as a measure of the virulence of the new or uncharacterized strain.

Abstract: A method of predicting the virulence of a new or uncharacterized PRRS virus isolate is provided wherein the isolate is injected into swine and allowed to replicate for a period of from about 3-15 days. During this period, the rate of virus growth and/or the magnitude of viremia is determined, and this data is compared with a corresponding growth rate and/or viremia magnitude of a PRRS virus isolate of known virulence, as a measure of the virulence of the new or uncharacterized isolate. Additionally, a method of selecting an isolate for inclusion in an immunogenic composition based on the predicted virulence is also provided, together with compositions incorporating attenuated forms of viruses predicted to be virulent.

Abstract: The present invention provides nucleic acid and amino acid sequences useful as the immunogenic portion of vaccines or immunogenic compositions effective for lessening the severity of the clinical symptoms associated with Lawsonia intracellularis infection or conferring protective immunity to an animal susceptible to such infection. Preferred amino acid sequences are selected from the group consisting of 1) a polypeptide comprising a sequence selected from the group consisting of SEQ ID Nos.

Abstract: A hand covering configured to enclose a human hand, fingers and thumb, having a dorsal side and a palm side. The hand covering includes a wrist portion and a hand portion. The hand portion includes at least one digit receptacle and a thumb receptacle. An opening is formed in the dorsal side of the hand covering, and extends from a location rearward of the thumb receptacle, across the dorsal side, to a side of the hand covering opposite the thumb receptacle. The opening is configured to allow the digit receptacle and the thumb receptacle to be removed from the digits and thumb of the wearer, while the wrist portion remains attached to the wearer and covers a dorsal side of the wearer's hand.

Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.

Abstract: The present invention relates to a method for prevention of the transmission of a pathogen of an animal of a first species to an animal of a second species characterized in that antigen of a pathogen of an animal of a first species is used for the immunization of an animal of a second species against the pathogen of the animal of the first species, wherein the administration of said antigen results in the reduction or the absence of the reproduction of pathogen of the animal of the first species in an animal of the second species.

Abstract: A hand covering configured to enclose a human hand, fingers and thumb, having a dorsal side and a palm side. The hand covering includes a wrist portion and a hand portion. The hand portion includes at least one digit receptacle and a thumb receptacle. An opening is formed in the dorsal side of the hand covering, and extends from a location rearward of the thumb receptacle, across the dorsal side, to a side of the hand covering opposite the thumb receptacle. The opening is configured to allow the digit receptacle and the thumb receptacle to be removed from the digits and thumb of the wearer, while the wrist portion remains attached to the wearer and covers a dorsal side of the wearer's hand.

Abstract: A rowing device with articulating oars FIG. 4 that are connected to outriggers FIG. 1 at the point of articulation. While the rower sits on a fixed seat 6, said outriggers 4 are foot operated 2 and function in the opposite direction as the feet through a system of cables 12 and sheaves 11.

Abstract: The present invention provides a composition and an improved single dose vaccine against E. rhusiopathiae and an improved single dose vaccine against E. rhusiopathiae and H. parasuis which provides one or more of the following: 1) confers effective immunity against E. rhusiopathiae and/or H. parasuis; 2) decreases the risk of developing clinical signs of E. rhusiopathiae and/or H. parasuis infection; 3) induces an immune response against E. rhusiopathiae and/or H. parasuis; and 4) has a DOI against E. rhusiopathiae and/or H. parasuis of at least four months. The composition or E. rhusiopathiae vaccine as well as the combined E. rhusiopathiae-H. parasuis composition or vaccine each includes a bacterial component of inactivated E. rhusiopathiae bacteria and a suitable adjuvant. The combined E. rhusiopathiae-H. parasuis composition or vaccine further includes an amount of H. parasuis antigen. The vaccines can be administered to animals in any conventional manner.

Abstract: A method of predicting the virulence of a new or uncharacterized PRRS virus isolate is provided wherein the isolate is injected into swine and allowed to replicate for a period of from about 3-15 days. During this period, the rate of virus growth and/or the magnitude of viremia is determined, and this data is compared with a corresponding growth rate and/or viremia magnitude of a PRRS virus isolate of known virulence, as a measure of the virulence of the new or uncharacterized isolate. Additionally, a method of selecting an isolate for inclusion in an immunogenic composition based on the predicted virulence is also provided, together with compositions incorporating attenuated forms of viruses predicted to be virulent.

Abstract: A method of predicting the virulence of a new or uncharacterized PRRS virus strain is provided wherein the strain is injected into swine and allowed to replicate for a period of from about 3-15 days. During this period, the rate of virus growth and/or the magnitude of viremia is determined, and this data is compared with a corresponding growth rate and/or viremia magnitude of a PRRS virus strain of known virulence, as a measure of the virulence of the new or uncharacterized strain.

Abstract: A wood or coal burning stove having walls defining a fire chamber with a flue disposed in one of the walls. A door provides access to the fire chamber, and a vent for controlling the combustion air is provided in the door. A manifold connected to inlet and outlet pipes passing through the walls provides for circulation of water through the fire chamber to heat the water with a fire burning in the fire chamber. Fuel supporting members extend downwardly from the manifold to support the fuel below the manifold, a number of generally U-shaped pipes with both ends of each pipe in fluid communication with the manifold providing the fuel supporting members. A baffle or like structure is provided in the manifold for preventing short-circuiting between the inlet and outlet pipes, and the manifold is supported in a generally horizontal plane.